800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Back To Doctor Search

Parth A. Desai, MBBS, MD

Parth A. Desai
Schedule Appointment

  • Assistant Professor

Specialties

Thoracic Medical Oncology, Head and Neck Medical Oncology

Loading ...
About Me
Publications
About Me
Languages
  • Hindi
  • English
Education

07/2016-06/2019: Residency training, Department of Internal Medicine, UT Health San Antonio, San Antonio,Texas.

05/2011-05/2014: Anatomical & Clinical Pathology residency training, Maulana Azad Medical College, New Delhi, Delhi, India.


Internship

03/2008-03/2009: Rotating Clinical medicine Internship, New Civil Hospital, Govt. Medical College, Surat,India.


Medical School

09/2003-03/2008: Government Medical College, Surat, India

Board Certifications
  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hematology
  • American Board of Internal Medicine - Medical Oncology
Awards and Honors
  • 2021- NCI Director’s award for pioneering patient-driven research discovering tractable therapeutic vulnerabilities of small cell lung cancer genomic subgroups (part of SCLC Clinical reseach team).
  • 2018- “PGY-2 Resident of the year” & “Most Compassionate PGY-2 Resident” awards at UT HealthSan Antonio Internal Medicine Residency Program, USA.
  • 2017- 1st prize Medical Jeopardy at South Texas ACP meeting, Austin, USA.
  • 2017- “Intern of the year”, “Most Compassionate Intern” & “Best teaching Intern” awards at UT Health San Antonio Internal Medicine Residency Program, USA. 
  • 2014- 2nd Prize Quiz held in IAPM-Delhi Chapter, AIIMS, India.
  • 2012- “Best Poster Award” Cytocon, Bhubaneswar, India.
  • 2008- Table tennis champion in Doubles event in Intercollege Sports Week Competition, Surat, India.
  • 2007- 1st prize in Quiz- Perinatology forum for World Breastfeeding week, Surat, India. 
  • 2005- 1st position in Veer Narmad South Gujarat University, 2nd year MBBS, India.
  • 2021- NCI Director’s award for pioneering patient-driven research discovering tractable therapeutic vulnerabilities of small cell lung cancer genomic subgroups (part of SCLC Clinical reseach team).
  • 2018- “PGY-2 Resident of the year” & “Most Compassionate PGY-2 Resident” awards at UT HealthSan Antonio Internal Medicine Residency Program, USA.
  • 2017- 1st prize Medical Jeopardy at South Texas ACP meeting, Austin, USA.
  • 2017- “Intern of the year”, “Most Compassionate Intern” & “Best teaching Intern” awards at UT Health San Antonio Internal Medicine Residency Program, USA. 
  • 2014- 2nd Prize Quiz held in IAPM-Delhi Chapter, AIIMS, India.
  • 2012- “Best Poster Award” Cytocon, Bhubaneswar, India.
  • 2008- Table tennis champion in Doubles event in Intercollege Sports Week Competition, Surat, India.
  • 2007- 1st prize in Quiz- Perinatology forum for World Breastfeeding week, Surat, India. 
  • 2005- 1st position in Veer Narmad South Gujarat University, 2nd year MBBS, India.
Ratings & Reviews

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient Comments

Loading ...
Offices

Office Locations

Fox Chase Cancer Center

333 Cottman Avenue

Philadelphia, PA 19111

Phone: 888-369-2427

Fox Chase Cancer Center at Temple University Hospital

3401 N. Broad Street

Philadelphia, PA 19140

Phone: 888-369-2427

Publications
Publications

1. Desai P, Aggarwal A. Breast Cancer in Women Over 65 years- a Review of Screening and Treatment Options. Clin Geriatr Med. 2021 Nov;37(4):611-623.
2. Thomas A, Desai P, Takahashi N. Translational research: A patient-centered approach to bridge the valley of death. Cancer Cell. 2022 May 6:S1535-6108.
3. Lissa D, Takahashi N, Desai P, Manukyan I, Schultz C, Rajapakse V, Velez M, Mulford D, Roper N, Nichols S, Vilimas R, Sciuto L, Chen Y, Guha U, Rajan A, Atkinson D, El Meskini R, Ohler ZW, Thomas A. Heterogeneity of Neuroendocrine Transcriptional States in Metastatic Small Cell Lung Cancer Tumors and Patient-Derived Models. Nature Comm. 2022 Mar 16 (in press).
4. Ethiraj P, Binu S, Holder K, Lin A, Qiu Z, Jaafar C, Elkhalili A, Desai P, Saksena A, Ritter J, Aguiar R. Cyclic- AMP signaling, MYC and HIF1α intersect to regulate angiogenesis in B-cell lymphoma. BJH. 2022 Mar 30 (in press).
5. Tlemsani C, Takahashi N, Pongor L, Rajapakse VN, Tyagi M, Wen X, Fasaye GA, Schmidt KT, Desai P, Kim C, Rajan A, Swift S, Sciuto L, Vilimas R, Webb S, Nichols S, Figg WD, Pommier Y, Calzone K, Steinberg SM, Wei JS, Guha U, Turner CE, Khan J, Thomas A. Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies. Sci Transl Med. 2021 Oct 13;13(615).
6. Thomas A, Takahashi N, Rajapakse VN, Zhang X, Sun Y, Ceribelli M, Wilson KM, Zhang Y, Beck E, Sciuto L, Nichols S, Elenbaas B, Puc J, Dahmen H, Zimmermann A, Varonin J, Schultz CW, Kim S, Shimellis H, Desai P, Klumpp-Thomas C, Chen L, Travers J, McKnight C, Michael S, Itkin Z, Lee S, Yuno A, Lee MJ, Redon CE, Kindrick JD, Peer CJ, Wei JS, Aladjem MI, Figg WD, Steinberg SM, Trepel JB, Zenke FT,
Pommier Y, Khan J, Thomas CJ. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress. Cancer Cell. 2021 Apr 12;39(4):566-579.e7.
7. Srour SA, Olson A, Ciurea SO, Desai P, Bashir Q, Oran B, Bose P, Mehta R, Patel KP, Pemmaraju N, Daver N, Verstovsek S, Champlin RE, Popat UR. Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation. Haematologica. 2021 Jul 1;106(7):1988-1990.
8. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent Prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol. 2017 Dec;30(12):1688-1697.
9. Thakral B, Medeiros LJ, Desai PA, Lin P, Yin CC, Tang G, Khoury JD, Hu S, Xu J,Loghavi S, Hu B, Oki Y, Li S. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab- EPOCH.Eur J Haematol.2017 Apr;98(4):415-421.
10. Wang XJ, L Jeffrey Medeiros, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, LiS. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma.Mod Pathol. 2017 Feb;30(2):194-203.
11. Xu J, Oki Y, Saksena A, Desai P, Lin P, Tang G, Yin CC, You MJ, Thakral B, Medeiros LJ, Li S. CD30 expressionand prognostic significance in R-EPOCH-treated patients with diffuse large B-cell lymphoma. Hum Pathol. 2017 Feb; 60:160-166.
12. Anil DP, Sudhir DP, Saksena A, Khurana N. An Affordable, Indigenous Polarizer-Analyzer System with In-built Retardation Plate Function to Detect Birefringence using 3D Glasses: An Experience. J Clin Diagn Res. 2016 Jan;10(1):EC12-4.
13. Li S, Saksena A, Desai P , Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget. 2016 Jun 21;7(25):38122-38132.
14. Saksena A, Gautam P, Desai P, Gupta N, Dubey AP, Singh T. Side scatter versus CD45 flow cytometric plot can distinguish acute leukemia subtypes. Indian J Med Res. 2016 May;143(Supplement):S17-S22.
15. Mulanovich VE, Desai PA, Popat UR. Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies. AIDS. 2016 Nov 13;30(17):2653-2657.